The role of intranasal esketamine in treatment-resistant depression

INTRODUCTION: Major depressive disorder (MDD) is a highly prevalent clinical condition with a leading cause of disability worldwide. Unfortunately, about 1/3 of patients with MDD fail to achieve remission despite treatment with multiple antidepressants and are considered to have treatment-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraga, A., Esteves-Sousa, D., Facucho-Oliveira, J., Albuquerque, M., Costa, M., Espada-Santos, P., Moutinho, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475877/
http://dx.doi.org/10.1192/j.eurpsy.2021.1278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475877/
http://dx.doi.org/10.1192/j.eurpsy.2021.1278

Ejemplares similares